Sponsored LinkedIn post
A dedicated post to introduce your brand to my audience.
Co-founder & CEO @ Lifebloom · Biodesigning tomorrow’s ingredients · Writing about what biology teaches business
Companies pay Chris to write a post about their product on LinkedIn.
This page is where they book it. Below: Chris's audience, recent posts and price. Naano, the platform behind this page, handles the brief, your approval of the post and the payment.
€419per post, fixed price
You approve the post before it goes live
Looking for Chris? View LinkedIn profileA creator yourself? Create your own page
Most people building in biotech are applying the wrong growth model. Biology doesn't scale the way software does. The frameworks that built Silicon Valley break when you introduce physical constraints, 18–36 month scale-up timelines, and downstream processing that eats 60–70% of your margin. I'm building Lifebloom, a biotech transforming cyanobacteria into a new class of active and functional ingredients for healthier skin and hair. Our first products harness the biopolymer’s native properties, with future derivatives designed to carry, protect and deposit active molecules. In 18 months we have gone from slide deck to validated molecule, from kitchen-built bioreactor to functioning lab setup. Greentech positioning to health biotech, after customer discovery revealed that sustainability is number four on every personal care brand's priority list, behind performance, cost, and regulatory compliance. I write about what that journey actually looks like. The gap between how biomanufacturing is talked about and how it works. What investors get wrong when they apply software playbooks to physical-world companies. What biology teaches us about business. If you're building in deep tech, investing in biomanufacturing, or trying to understand what the bioeconomy actually requires, tag along.
My most engaged audience
31% Engineering / Data
From 109 people who reacted to or commented on my posts
Public LinkedIn data · Nov 3, 2026
Come work with us! We are looking for an experienced 𝗰𝗼𝘀𝗺𝗲𝘁𝗶𝗰 𝗰𝗵𝗲𝗺𝗶𝘀𝘁 / 𝘀𝗸𝗶𝗻𝗰𝗮𝗿𝗲 𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗼𝗿 to join us on a consultancy or part-time basis. At Lifebloom, we work with cyanobacteria, one of the oldest forms of life on Earth 🦠🌍 These tiny microorganisms have incredible potential as sustainable factories for the next generation of high-performance cosmetic ingredients. After screening 100+ cyanobacterial molecules, we identified an overlooked molecule with exciting potential for skin and hair care. Now we are working to bring it to market. But developing an innovative ingredient is only half the challenge. We also need to demonstrate its performance in real skincare formulations. 𝗔𝗻𝗱 𝘁𝗵𝗮𝘁'𝘀 𝘄𝗵𝗲𝗿𝗲 𝘄𝗲 𝗻𝗲𝗲𝗱 𝘆𝗼𝘂! We're looking for someone with proven experience in developing high-quality skincare formulations, both on paper and hands-on in the lab. You'll work directly with our founding team to develop formulations for clinical efficacy studies and customer sampling, while providing technical and strategic guidance. 📍 Ideally based in Denmark, with access to a formulation lab. Otherwise, we have lab facilities in Malmö. 👉 Full job description and application details: https://lnkd.in/eCq-WEQK If this sounds like you, or someone you know, we'd love to hear from you. Jan Karlsen Andreia Lopes
We are a technical-commercial founding team, and I see that as a huge advantage. When starting Lifebloom, I knew very little about biotechnology. I entered a scientific field with a commercial lens. Instead of starting with what was scientifically possible, my instinct was to ask: What problem does this solve? Is it better than existing solutions? Over time, I have learned a lot of science. I needed to understand what our molecules do, why they do it, their mode of action, how they compare with other materials, and where the scientific evidence is strong or weak. But I don’t need to know every detail of our tech. My co-founder, Jan does that. I need to understand the science well enough to make good strategic and commercial calls. And I think there is an advantage to stopping there. Science gives you an enormous number of interesting directions to pursue. A CEO’s job is not necessarily to understand every detail. It is to identify which details matter commercially and turn them into decisions about where to focus the company. Great science is not the same thing as a great product. A scientifically fascinating molecule can still solve no meaningful customer problem. It can be too expensive, impossible to formulate, difficult to scale, poorly differentiated, or simply something nobody wants to buy. And even when great science becomes a great product, the product still doesn’t sell itself. It needs positioning. Evidence. A compelling narrative. Distribution. Relationships. Persistence. Sales. My co-founder will tell you how to make the molecule. I will tell you why we should make it in the first place, and why anyone should care. That combination is what makes Lifebloom a strong founding team.
Here is what I have learned from working a decade in personal care (which feels strange to say). Beauty and personal care looks like a science-driven industry from the outside. And science does matter. But inside the industry, the final decisions about claims, ingredients, and stories are often made by marketing. Back when I was building NØIE, we tried hard to work the other way around. We did not choose ingredients because they made a good story. We built products around what the evidence showed us. I am happy to see Christian and the team still staying true to that today. Other brands do this too. But most of the industry is marketing-led. That has become much more obvious to me now that I have moved upstream, from building brands to building the ingredients those brands buy. I am seeing a clear tension between science and marketing. You need science to open the door to marketing. But when marketers make the final calls, there’s a tendency for the science to be designed, interpreted, and packaged around the story they want to tell. An in vitro effect becomes a mechanism. A mechanism becomes a clinical narrative. A correlation starts sounding like causation. And before long, claims like cellular rejuvenation, DNA protection, epigenetic anti-aging, and mitochondrial activation are used with more certainty than the evidence can actually support. As an ingredient company, that leaves us with an uncomfortable question. 𝗗𝗼 𝘄𝗲 𝗽𝗹𝗮𝘆 𝗯𝘆 𝘁𝗵𝗲 𝗿𝘂𝗹𝗲𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆, 𝗼𝗿 𝗱𝗼 𝘄𝗲 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝘁𝗵𝗲𝗺? Commercially, I understand the temptation. If everyone else is selling a compelling biological story, showing up with a more honest but less exciting one is a hard sell, especially when the buyer is thinking in sales numbers rather than scientific certainty. But maybe that is exactly what the industry needs more of. A clearer separation between what was measured, what is inferred, and what is still just a marketing hypothesis. I’d love to hear from cosmetic scientists, formulators, AND marketers: 𝗗𝗼 𝗶𝗻𝗴𝗿𝗲𝗱𝗶𝗲𝗻𝘁 𝘀𝘂𝗽𝗽𝗹𝗶𝗲𝗿𝘀 𝗼𝘃𝗲𝗿𝘀𝘁𝗮𝘁𝗲 𝘄𝗵𝗮𝘁 𝘁𝗵𝗲𝗶𝗿 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝗽𝗿𝗼𝘃𝗲𝘀?
Choose a format for your next LinkedIn collaboration.
A dedicated post to introduce your brand to my audience.
Your collaboration, managed on Naano
How does this price compare? B2B creator rates 2026
Based on 109 people who reacted to or commented on my posts. Percentages use the profiles that could be classified.
Based on 109 people who reacted to or commented on my posts. Percentages use the profiles that could be classified.
Based on 109 people who reacted to or commented on my posts. Percentages use the profiles that could be classified.
Based on 109 people who reacted to or commented on my posts. Percentages use the profiles that could be classified.
Storefront by Naano · Create yours
Chris Lykke Christiansen is a B2B LinkedIn creator based in Denmark with 4,641 followers, posting about Marketing and Outreach. On Naano, one sponsored LinkedIn post by Chris Lykke Christiansen costs €419, a fixed price per post.
The Naano team casts the creators, writes the briefs, reviews every draft with you and reports results per creator. You approve the shortlist and every draft.